Skip to main content
. Author manuscript; available in PMC: 2009 Mar 1.
Published in final edited form as: Clin Immunol. 2007 Dec 26;126(3):277–281. doi: 10.1016/j.clim.2007.11.009

Table 1.

Characteristics of all subjects tested by mixed lymphocyte cultures and/or ELISPOT assays.

Recipient
HLA Alleles Shared With Donor
MLC vs. Donor PBMCs MLC vs. DTCs
Subject Yearsa Race Sex Donor Sex Genetics A B C DRB1 ISb
DIG001 1.7 W F M IDM 1 0 1 0 N X -
DIG007 5.8 A F M 22q11 0 0 0 1 N - X
DIG010 5.6 W M M CHARGE 0 0 0 1 N - X
DIG012 5.1 B F M IDM 0 0 1 0 N - X
DIG019 5.0 B F F 22q11 1 0 0 1 N - X
DIG020 4.2 B F M CHARGE 0 0 NT 0 N - X
DIG102 0.9 W M M 22q11 0 0 0 0 Y X -
DIG105 4.2 W F M IDM 1 0 NT 0 Y - Xc
DIG106 3.9 W M M None 1 1 1 0 Y - X
DIG107 4.1 W M M CHARGE 1 0 NT 0 Y - X
DIG112 2.9 W M M CHARGE 1 0 0 0 Y - X
DIG120 1.3 W M M CHARGE 1 1 1 1 Y - X
a

Years after transplantation at time sample was obtained.

b

Abbreviations: 22q11, hemizygosity at 22q11; A, Asian; B, Black; CHARGE association, coloboma, heart defect, atresia of the choanae, retardation of growth and development, genital hypoplasia, ear malformation/hearing loss; IDM, infant of a diabetic mother; IS, received peri-transplantation immunosuppression; NT, not tested; W, White

c

Performed twice.